The U.S. Food and Drug Administration (FDA) held a webinar on January 10 reviewing its final guidance for creating medical products using 3D printers.
The meeting covered the agency's current stance on device design and manufacturing, testing considerations, and additional labeling considerations. It highlighted three significant changes to the initial guidance:
- A new section on cybersecurity and personally identifiable information
- Updated labeling considerations
- The replacement of the term "cleaning" with "removing manufacturing material"
The transcript and slides from the webinar are available online.
